Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/49967
Title: In vitro selection and characterization of mutants in TEM-1-producing Escherichia coli by ceftazidime and ceftibuten
Authors: Perilli, M.
Segatore, B.
Tavio, M. 
Setacci, D.
Celenza, G.
De Santis, F.
Pellegrini, C.
Rossolini, G. M.
Amicosante, Gianfranco
Keywords: Tem Beta-Lactamase
Amino-Acid Substitutions
Antibiotic-Resistance
Evolution
Issue Date: 2007
Publisher: 1120-009X
Journal: Journal of Chemotherapy 
Abstract: The present work was undertaken to study the ability of ceftazidime and ceftibuten to select in vitro resistant mutants of Escherichia coli HB101 harboring bla(TEM-1) beta-lactamase gene. Minimum inhibitory concentrations (MICs) of ceftazidime and ceftibuten were increased by a factor of 32, overcoming in the case of ceftazidime the breakpoint for clinical resistance. Outer membrane protein analysis and PCR for bla(TEM) alleles revealed that ceftazidime and ceftibuten select for different resistance mechanisms. Ceftazidime created mutants that encode an extended-spectrum beta-lactamase (TEM-12) and exhibit decreased expression of OmpF. Ceftibuten was unable to select for extended-spectrum beta-lactamase expressing mutants but reduced the expression of two porins, OmpC and OmpF. The stability of ceftibuten to hydrolysis and the difference in the structure of these beta-lactam antibiotics could be responsible for the selection of different mechanisms of resistance.
URI: http://hdl.handle.net/10553/49967
ISSN: 1120-009X
DOI: 10.1179/joc.2007.19.2.123
Source: Journal of Chemotherapy[ISSN 1120-009X],v. 19, p. 123-126
Appears in Collections:Artículos
Show full item record

SCOPUSTM   
Citations

3
checked on May 9, 2021

WEB OF SCIENCETM
Citations

3
checked on May 9, 2021

Page view(s)

6
checked on May 10, 2021

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.